PreveCeutical Medical Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PRVCF research report →
About the company
Vancouver, Canada-based PreveCeutical Medical Inc. operates as a health sciences company, focusing on the creation of both preventative and curative treatments derived from organic and nature-identical substances. The company's innovative pipeline includes a cannabinoid Sol-Gel Delivery system designed for nose-to-brain administration, offering potential relief for ailments such as pain, inflammation, seizures, and various neurological disorders.
- CEO
- Stephen Van Deventer
- IPO
- 2017
- Employees
- 7
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $6.46M
- P/E
- -5.00
- P/S
- 0.00
- P/B
- -1.44
- EV/EBITDA
- -4.08
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 23.09%
- ROIC
- 339.03%
- Revenue
- $0 · 0.00%
- Net Income
- $-1,583,019 · -34.76%
- EPS
- $-0.00 · -22.73%
- Op Income
- $-3,364,366
- FCF YoY
- -301.74%
- 52W High
- $0.04
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- 0.01
- Avg Volume
- 18.89K
Get TickerSpark's AI analysis on PRVCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PRVCF coverage
Recent articles, reports, and earnings notes.
No research on PRVCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PRVCF report →Similar companies
Peers in the same neighborhood.